Plasma selenium and peripartum cardiomyopathy in Bamako, Mali

Peripartum heart failure due to unexplained dilated cardiomyopathy is a common disorder as Savannak-Sahelian Africa. One of the many suspected risk factors identified is selenium deficiency. The purpose of this study was to measure plasma selenium levels in patients with peripartum heart failure due to cardiomyopathy in Bamako, Republic of Mali and compare data with healthy Sahalian women with the same obstetrical status. Plasma selenium was measured in a patient group consisting of 28 Malian women presenting peripartum heart failure and in a control group of 28 healthy breast-feeding Nigerien women of comparable age. The criteria for matching the two groups was parity (similar number of deliveries) since multiparity is a risk factor for peripartum cardiomyopathy. The Wilcoxon test (nonparametric) was used to compare the 2 groups considering up value < 0.05 as significant. Plasma selenium was significantly lower in patients from Mali than in controls from Niger (65 +/- 17 ng/ml vs. 78 +/- 17 ng/ml, p = 0.01). The results of this study showing lower plasma selenium in Bamako patients with peripartum cardiomyopathy than in a matching healthy control population confirms the previous data from the Niamey study.

Medienart:

Artikel

Erscheinungsjahr:

2004

Erschienen:

2004

Enthalten in:

Zur Gesamtaufnahme - volume:64

Enthalten in:

Medecine tropicale : revue du Corps de sante colonial - 64(2004), 2 vom: 03., Seite 151-4

Sprache:

Französisch

Weiterer Titel:

Sélénium plasmatique et cardiomyopathie péripartum a Bamako (Mali)

Beteiligte Personen:

Cénac, A [VerfasserIn]
Touré, K [VerfasserIn]
Diarra, M B [VerfasserIn]
Sergeant, C [VerfasserIn]
Jobic, Y [VerfasserIn]
Sanogo, K [VerfasserIn]
Dembele, M [VerfasserIn]
Fayol, V [VerfasserIn]
Simonoff, M [VerfasserIn]

Themen:

English Abstract
H6241UJ22B
Journal Article
Research Support, Non-U.S. Gov't
Selenium

Anmerkungen:

Date Completed 06.04.2005

Date Revised 21.11.2013

published: Print

Citation Status MEDLINE

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM151332568